Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page footer shows revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-14T20:39:24.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T20:54:45.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with the basic HTML header and a Home link, replacing the previous study-record content; several navigation and document-related sections are removed in this view.
    Difference
    20%
    Check dated 2026-09-23T21:38:54.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 has been added, replacing the previous v3.6.6 to record an updated page revision.
    Difference
    0.0%
    Check dated 2026-09-16T22:24:28.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the documentation/version history.
    Difference
    0.0%
    Check dated 2026-09-02T19:27:42.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A new funding identifier '2015 ( U.S. NIH Grant/Contract )' was added next to the study identifiers, indicating NIH support for the trial. The addition provides funding context but does not change the study design or eligibility.
    Difference
    0.0%
    Check dated 2026-08-26T19:44:32.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.